#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14560	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2227	782.2	0	.	n	.	0	G1207A	SNP	1207	1207	G	1474	1474	A	952	A,T,G	949,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14560	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2227	782.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1717	1717	T	909	T,G,C	906,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14560	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2227	782.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	922	C,G	921,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24608	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4029	761.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1870	1870	A	1000	A,C	998,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24608	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4029	761.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2504	2504	C	833	C,T	832,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24608	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4029	761.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2578	2578	A	732	A,T	731,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24608	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4029	761.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3130	3130	C	893	C	893	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1692	folP	852	852	99.77	folP.l6.c17.ctg.1	1882	111.9	0	.	p	.	0	D71H	NONSYN	211	213	GAT	749	751	CAT	136;135;135	C;A;T	136;135;135	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1692	folP	852	852	99.77	folP.l6.c17.ctg.1	1882	111.9	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1148	1150	GTA	174;170;172	G;T,G;A,C	174;169,1;171,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1692	folP	852	852	99.77	folP.l6.c17.ctg.1	1882	111.9	1	SNP	p	R228S	0	.	.	682	684	CGC	1220	1222	CGC	157;153;152	C;G;C	157;153;152	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4464	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	4034	137.9	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1350	1352	ATA	166;169;168	A;T,G;A,C	166;168,1;167,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4464	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	4034	137.9	1	SNP	p	S91F	0	.	.	271	273	TCC	873	875	TCC	172;172;173	T;C;C	172;172;173	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4464	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	4034	137.9	1	SNP	p	D95G	0	.	.	283	285	GAC	885	887	GAC	172;173;174	G,A;A;C	171,1;173;174	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4464	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	4034	137.9	1	SNP	p	D95N	0	.	.	283	285	GAC	885	887	GAC	172;173;174	G,A;A;C	171,1;173;174	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1840	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1962	116.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	946	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1625	72.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1789	1791	GCA	255;255;254	G;C;A	255;255;254	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	1	SNP	p	D86N	0	.	.	256	258	GAC	742	744	GAC	234;236;235	G;A,C,G;C,A	234;233,2,1;233,2	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	1	SNP	p	S87I	0	.	.	259	261	AGT	745	747	AGT	230;233;231	A,C;G,C;T	228,2;232,1;231	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	1	SNP	p	S87W	0	.	.	259	261	AGT	745	747	AGT	230;233;231	A,C;G,C;T	228,2;232,1;231	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	1	SNP	p	S87R	0	.	.	259	261	AGT	745	747	AGT	230;233;231	A,C;G,C;T	228,2;232,1;231	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5064	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3399	185.4	1	SNP	p	S88P	0	.	.	262	264	TCC	748	750	TCC	231;230;229	T;C;C	231;230;229	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3730	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3244	143.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1873	1875	GGC	201;197;197	G;G,T;C	201;196,1;197	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1479	1481	GCA	215;216;218	G,A,C;C,T;A	213,1,1;215,1;218	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1482	1484	ATC	220;218;221	A;T,A;C	220;217,1;221	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1494	1496	GTG	221;218;220	G;T;G,A	221;218;219,1	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1494	1496	GTG	221;218;220	G;T;G,A	221;218;219,1	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1998	2000	ACC	194;197;197	A,C;C,G;C,G	192,2;196,1;196,1	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2052	2054	GCG	183;186;181	G,T;C;G	182,1;185;181	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2052	2054	GCG	183;186;181	G,T;C;G	182,1;185;181	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2175	2177	GGC	185;187;187	G,C;G,T;C	183,2;186,1;187	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2184	2186	GGC	187;185;185	G,C;G;C	186,1;185;185	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	3528	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2928	150.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2202	2204	CCG	199;200;197	C;C;G	199;200;197	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5418	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3656	184.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1887	1889	CTG	224;224;222	C,T;T;G	223,1;224;222	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2260	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2268	124.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	833	833	C	162	C	162	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	790	792	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	793	795	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	A222V	NONSYN	664	666	GCT	805	807	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	817	819	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	840	842	GTA	3;3;3	G;T;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	326	porB1a	984	307	90.03	porB1a.l15.c30.ctg.1	1072	30.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	849	849	A	3	A	3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	707	709	ATG	240;239;239	A;T,C;G,T	240;238,1;238,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1082	1084	CAA	239;240;239	C;A;A	239;240;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1289	1291	GAT	283;282;281	G,T;A;T	282,1;282;281	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1292	1294	GGT	281;279;277	G;G;T,G,A	281;279;275,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1298	1300	GCT	266;260;260	G;C;T	266;260;260	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1313	1315	ACT	268;270;273	A;C,G;T	268;269,1;273	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1424	1426	ATG	307;309;305	A;T;G,A	307;309;304,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1427	1429	AGC	303;303;303	A;G;C	303;303;303	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1430	1432	GGT	303;301;299	G;G;T,C	303;301;298,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1544	1546	AAC	253;250;245	A;A;C	253;250;245	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3016	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	1835	198.7	1	SNP	p	G120K	0	.	.	358	360	GGC	1013	1015	GGC	207;206;206	G;G;C	207;206;206	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10086	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5284	237.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2229	2231	CAT	261;259;263	C;A;T,G	261;259;262,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1406	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1557	112.4	1	SNP	p	V57M	0	.	.	169	171	GTG	704	706	GTG	228;228;232	G;T;G,T,C	228;228;230,1,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
